Armata Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Armata Pharmaceuticals stock have an average target of 15, which predicts a 41.51% increase from the current stock price of 10.6.

Price Target: $15 (+41.51%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$15	$15	$15	$15
Change	+41.51%	+41.51%	+41.51%	+41.51%

Analyst Ratings

The average analyst rating for Armata Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	1	1	1	1	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $9 → $15	Strong Buy	Maintains	$9 → $15	+41.51%	Feb 23, 2026
Debanjana Chatterjee Jones Trading	Jones Trading	Strong Buy Initiates $15	Strong Buy	Initiates	$15	+41.51%	Jan 5, 2026
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $7 → $9	Strong Buy	Maintains	$7 → $9	-15.09%	May 19, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-33.96%	Dec 19, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	-33.96%	Nov 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

4.64M

from 5.17M

-10.30%

from 5.17M

Revenue Next Year

n/a

from 4.64M

EPS This Year

-1.67

from -0.89

EPS Next Year

-1.11

from -1.67

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	823.00K	4.47M	5.51M	4.53M	5.17M	4.64M	-
Revenue Growth	-	443.62%	23.11%	-17.77%	14.24%	-10.30%	-
EPS	-1.35	-0.96	-1.08	-1.91	-0.89	-1.67	-1.11
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	5.6M	n/a
Avg	4.6M	n/a
Low	3.7M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	7.6%	-
Avg	-10.3%	-
Low	-28.0%	-

EPS Forecast

EPS	2025	2026
High	-1.62	-1.14
Avg	-1.67	-1.11
Low	-1.70	-1.07

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.